Greg Cavers
CIK: 0002116548
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HELP
Helus Pharma Inc.
Officer
Discretionary Trading P&L
Holdings
About Cavers Greg
Cavers Greg (SEC CIK 0002116548) files insider reports with the SEC as Chief Financial Officer of Helus Pharma Inc. (HELP).
Signal8 holds 2 ownership filings by Cavers Greg (1 Form 3, 1 Form 4), filed on Oct 1, 2026. Those filings report 1 transaction, the latest on Sep 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cavers Greg's filings is in TORONTO.
Recent filings by Cavers Greg
- Sep 29, 2026: Open-market purchase of HELP shares (Form 4, code P).
Other insiders filing for Helus Pharma Inc. (HELP)
- Durgam Suresh K., Director
- Lewis-Hall Freda C, Director
- Inamdar Amir, Director
- Froese Grant, Director
- Hoskins Eric, Director
- Lawson Mark, Director